You have recently viewed:
Write a review
Write a review
Write a review
Would you like to write a review?

CCRstudies.com

CCRstudies.com in New London, CT
342 Montauk Ave., New London, CT 06320
(860) 443-4567

Contacts

Street address:
342 Montauk Ave.

City / suburb:
New London

County:
New London

State:
Connecticut

ZIP code:
06320

Phone:
(860) 443-4567 (Primary Phone)

E-mail:
info@ccrstudies.com

GPS Longitude:
-72.1061935424805

GPS Latitude:
41.337329864502

Business description

Provide medical services for volunteers participating in clinical research studies.

What is a Clinical Trial? A clinical trial is a research study of a medication, device or technology that is used to treat a particular medical condition in a particular population of people. The purpose of these studies is to find out whether an investigational medication is safe to use and effective for treatment of various medical conditions, or to compare existing medications that have been approved for the treatment of a particular condition. At Coastal Connecticut Research, we review many trials for medications involving women's health. We strive to bring to our community trials that are respectful of the needs of our patients, and that will be likely to provide beneficial information to the medical community. These trials are sponsored by major pharmaceutical and biotechnology

General information

Business data
Estimated number of employees: 5 to 9
City / suburb: New London, CT
County: New London
Products

Endometriosis, drugs related to diabetic neuropathy, Arthritis Treatment, Depression

Brands

Celebrex, Naproxen, Ibuprofen.

Not quite what you're looking for? See recommended web results

Is this your business? Claim this profile to get thousands of free views!

QR code with CCRstudies.com contacts

QR code with CCRstudies.com contacts
Install a QR code reading app on your smartphone to scan and convert it to the company contact information.

Reviews

There are no reviews on CCRstudies.com yet.
Be the first to write a review about your experience with the company.

More details about this business

According to our records, this business is located at 342 Montauk Ave. in New London (in New London County), Connecticut 06320, the location GPS coordinates are: 41.337329864502 (latitude), -72.1061935424805 (longitude). CCRstudies.com is categorized under Health Care Alternatives. The company employs approximately 5 to 9 people. You can contact the company by phone at (860) 443-4567. Open from 8:00 am until 5:00 pm (Monday - Thursday), from 8:00 am until 2:30 pm (Friday).
Not satisfied? Select a reasonRate this pageSend feedback

Or try our search form or quick navigation by category and location

Hours
Mon
8:00 am - 5:00 pm
Tue
8:00 am - 5:00 pm
Wed
8:00 am - 5:00 pm
Thu
8:00 am - 5:00 pm
Fri
8:00 am - 2:30 pm
Sat
Closed
Sun
Closed
Similar companies
Ameriplan Health Care
112 Popple Swamp, Litchfield, CT
Darien Center for Integrative Medicine
870 Post Road, Fairfield, CT
JMA MD Plus
New Haven, CT
Red Skye Therapy
110 Hatfield Hill Rd., New Haven, CT
Stan Baker- Acupuncture in Avon
35 Nod Road, Suite 106, Hartford, CT
Also viewed
Peninsula Publishing
1630 Post Road East, Unit 312, Fairfield, CT
Book Clubs: Publishing Only, Not Printed On Site
JD Events LLC
5520 Park Ave., Fairfield, CT
Foreign Trade Consultants
Connecticut Home Services LLC
9 Shelton Rd., New Haven, CT
Art Related Services

Top Stories
UBS flags buyback possibility after Second-quarter earnings beat
UBS , the world's largest wealth manager, on Tuesday signalled the possibility of resuming share buybacks later this year after generating more income than expected in the first six months and as it boosted...
Tue, Jul 21 2020
Greece calls EU recovery fund deal a 'national success'
Prime Minister Kyriakos Mitsotakis called a European Union deal on a post-pandemic recovery fund a "national success" that would allocate Greece around 72 billion euros ($82.38 billion) to help deal with...
Tue, Jul 21 2020
UBS second-quarter net profit dips as Swiss business dampens trading bonanza
UBS , the world's largest wealth manager, saw net profit drop 11% in the second quarter as higher trading activity failed to offset a pandemic-induced slump in retail and corporate banking.
Tue, Jul 21 2020